China Medical's Opzelura Cream Gets NMPA Approval for Vitiligo
CompanyDrug

China Medical’s Opzelura Cream Gets NMPA Approval for Vitiligo

Zhaoke Ophthalmology's Yuvezzi Gets FDA Nod for Presbyopia
CompanyDrug

Zhaoke Ophthalmology’s Yuvezzi Gets FDA Nod for Presbyopia

CSPC's SYS 6055 CAR-T Gets NMPA Nod for Lymphoma Trials
CompanyDrug

CSPC’s SYS 6055 CAR-T Gets NMPA Nod for Lymphoma Trials

AstraZeneca Commits $14.4B China Investment in Cell Therapy Push
Company

AstraZeneca Commits $14.4B China Investment in Cell Therapy Push

Ascletis ASC40 Phase III Success in Acne Vulgaris
Drug

Ascletis ASC40 Phase III Success in Acne Vulgaris

Thermo Fisher Reports Q4 Revenue Growth on AI Innovation
Company

Thermo Fisher Reports Q4 Revenue Growth on AI Innovation

TYK Medicines Asandeutertinib Gets China Priority Review for NSCLC Brain Metastases
CompanyDrug

TYK Medicines Asandeutertinib Gets China Priority Review for NSCLC Brain Metastases

Takeda Q3 Revenue Drops 3.3% on VYVANSE Generics, Raises Full-Year Forecast
Company

Takeda Q3 Revenue Drops 3.3% on VYVANSE Generics, Raises Full-Year Forecast

Tyligand Bio Files Hong Kong IPO with Phase II KRAS G12D Inhibitor TSN1611
CompanyDeals

Tyligand Bio Files Hong Kong IPO with Phase II KRAS G12D Inhibitor TSN1611

Hengrui Cancer Combo Gets NMPA Nod for Liver Cancer Trials
CompanyDrug

Hengrui Cancer Combo Gets NMPA Nod for Liver Cancer Trials

Genhouse Bio Files Hong Kong IPO with Phase II SHP2 Inhibitor GH21
CompanyDeals

Genhouse Bio Files Hong Kong IPO with Phase II SHP2 Inhibitor GH21

CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio
CompanyDeals

CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio